Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15909930rdf:typepubmed:Citationlld:pubmed
pubmed-article:15909930lifeskim:mentionsumls-concept:C0042776lld:lifeskim
pubmed-article:15909930lifeskim:mentionsumls-concept:C0206510lld:lifeskim
pubmed-article:15909930lifeskim:mentionsumls-concept:C0019196lld:lifeskim
pubmed-article:15909930lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:15909930lifeskim:mentionsumls-concept:C0069156lld:lifeskim
pubmed-article:15909930lifeskim:mentionsumls-concept:C0920283lld:lifeskim
pubmed-article:15909930lifeskim:mentionsumls-concept:C0445223lld:lifeskim
pubmed-article:15909930lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:15909930lifeskim:mentionsumls-concept:C1552599lld:lifeskim
pubmed-article:15909930lifeskim:mentionsumls-concept:C1704787lld:lifeskim
pubmed-article:15909930pubmed:dateCreated2005-5-24lld:pubmed
pubmed-article:15909930pubmed:abstractTextAbstract: In the search for inhibitors of the non-structural protein 3 (NS3)-associated NTPase/helicase activities of the hepatitis C virus (HCV), and of the related West Nile Virus (WNV), and Japanese Encephalitis Virus (JEV), random screening of a broad range of unrelated low-molecular weight compounds revealed that 4,5,6,7-tetrabromo-1H-benzotriazole (TBBT) is a good inhibitor of the helicase activity of HCV and WNV NTPase/helicases (IC50 >> 20 mM and 1.7 mM with a DNA substrate), but a very weak inhibitor of the JEV enzyme (IC50 >> 200 mM). The synthesis of new TBBT derivatives was undertaken and their inhibitory activities against HCV, WNV, and JEV NTPase/helicases and cytotoxicities were examined. The N-alkyl derivatives showed good activity and lower cytotoxicity than TBBT.lld:pubmed
pubmed-article:15909930pubmed:languageenglld:pubmed
pubmed-article:15909930pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15909930pubmed:citationSubsetIMlld:pubmed
pubmed-article:15909930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15909930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15909930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15909930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15909930pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15909930pubmed:statusMEDLINElld:pubmed
pubmed-article:15909930pubmed:monthDeclld:pubmed
pubmed-article:15909930pubmed:issn0001-6837lld:pubmed
pubmed-article:15909930pubmed:authorpubmed-author:BorowskiPeter...lld:pubmed
pubmed-article:15909930pubmed:authorpubmed-author:BaierAndreaAlld:pubmed
pubmed-article:15909930pubmed:authorpubmed-author:BretnerMariaMlld:pubmed
pubmed-article:15909930pubmed:authorpubmed-author:KulikowskiTad...lld:pubmed
pubmed-article:15909930pubmed:authorpubmed-author:LipniackiAndr...lld:pubmed
pubmed-article:15909930pubmed:authorpubmed-author:PiasekAndrzej...lld:pubmed
pubmed-article:15909930pubmed:authorpubmed-author:NajdaAndzelik...lld:pubmed
pubmed-article:15909930pubmed:authorpubmed-author:Podwi?skaRomu...lld:pubmed
pubmed-article:15909930pubmed:authorpubmed-author:ParuchKatarzy...lld:pubmed
pubmed-article:15909930pubmed:issnTypePrintlld:pubmed
pubmed-article:15909930pubmed:volume61 Suppllld:pubmed
pubmed-article:15909930pubmed:ownerNLMlld:pubmed
pubmed-article:15909930pubmed:authorsCompleteYlld:pubmed
pubmed-article:15909930pubmed:pagination26-8lld:pubmed
pubmed-article:15909930pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15909930pubmed:meshHeadingpubmed-meshheading:15909930...lld:pubmed
pubmed-article:15909930pubmed:meshHeadingpubmed-meshheading:15909930...lld:pubmed
pubmed-article:15909930pubmed:meshHeadingpubmed-meshheading:15909930...lld:pubmed
pubmed-article:15909930pubmed:meshHeadingpubmed-meshheading:15909930...lld:pubmed
pubmed-article:15909930pubmed:meshHeadingpubmed-meshheading:15909930...lld:pubmed
pubmed-article:15909930pubmed:meshHeadingpubmed-meshheading:15909930...lld:pubmed
pubmed-article:15909930pubmed:meshHeadingpubmed-meshheading:15909930...lld:pubmed
pubmed-article:15909930pubmed:meshHeadingpubmed-meshheading:15909930...lld:pubmed
pubmed-article:15909930pubmed:meshHeadingpubmed-meshheading:15909930...lld:pubmed
pubmed-article:15909930pubmed:meshHeadingpubmed-meshheading:15909930...lld:pubmed
pubmed-article:15909930pubmed:year2004lld:pubmed
pubmed-article:15909930pubmed:articleTitleInhibitors of the NTPase/helicases of hepatitis C and related Flaviviridae viruses.lld:pubmed
pubmed-article:15909930pubmed:affiliationLaboratory of Antimetabolites, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, 5A Pawi?skiego Str., 02-106 Warszawa, Poland. majka@ibb.waw.pllld:pubmed
pubmed-article:15909930pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15909930pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed